Actively Recruiting
Analgesia-First Sedation in Trauma Patients Comparing Intermittent Pain Medication Doses to Continuous Sedative Infusions with Daily Interruption
Led by MemorialCare Health System · Updated on 2025-07-09
170
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the best sedation and pain management approach for trauma patients needing mechanical ventilation. The study compares continuous sedative and pain medication infusions with an analgesia-first strategy, where sedatives are reserved for brief use as needed. Although sedation protocols have improved outcomes in medical ICU patients, it remains unclear which method is better for surgical trauma patients. Participants will be randomly assigned to receive either analgesia-first sedation using intermittent fentanyl doses with sedatives added only if necessary, or protocol-directed sedation with continuous infusions of analgesics and sedatives interrupted daily. Both groups will be managed with approved ICU protocols, with daily assessments for ventilator weaning. During the study, participants will be monitored for days on mechanical ventilation until successful extubation, as well as duration of weaning. Researchers will track ICU and hospital length of stay, sedation levels, pain control, and safety outcomes. The total participation time includes at least 28 days of outcome measurement, with regular assessments to guide sedation and ventilation management.
CONDITIONS
Brief Title
Analgesia-First Sedation in Trauma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Mechanically ventilated with expected duration of mechanical ventilation of at least 48 hours
- Started continuous sedative or analgesic infusions in the ICU
- Candidate for mechanical ventilation weaning
You will not qualify if you...
- Admission after resuscitation from cardiac arrest
- Significant neurological deficit from a chronic disorder
- History of alcohol dependence or illicit drug abuse
- Prior continuous sedative or analgesic administration from another institution
- Receiving neuromuscular blocking agents
- Allergy to midazolam, lorazepam, or propofol
Research Team
M
Maged Tanios, MD, MPH
H
Hyunsoon Park, RN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here